Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com

Retrieved on: 2022-05-30 17:43:17

Tags for this article:

Click the tags to see associated articles and topics

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com. View article details on HISWAI: https://www.defenseworld.net/2022/05/30/brainstorm-cell-therapeutics-nasdaqbcli-coverage-initiated-by-analysts-at-stocknews-com-2.html

Excerpt

The biotechnology company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.02). During the same quarter in the ...

Article found on: www.defenseworld.net

View Original Article